Orca Bio

Biotech & Life Sciences · Menlo Park, United States · Founded 2016

Orca Bio is a biotechnology startup that operates in the cell therapy market. The company's primary focus is to enhance the benefits of cell therapies, which are treatments that use the body's own cells to fight diseases. These therapies have the potential to revolutionize healthcare, particularly for conditions that currently lack effective treatments. Orca Bio aims to improve these therapies by making them safer and more effective, thereby delivering better outcomes for patients. The company's clients are primarily healthcare providers and patients. Healthcare providers may use Orca Bio's therapies to treat their patients, while patients may receive these therapies as part of their treatment plans. Orca Bio's business model revolves around the research, development, and commercialization of its cell therapies. The company makes money by selling these therapies to healthcare providers. Orca Bio is also dedicated to fostering a strong team culture. The company values its employees and is always looking for talented individuals to join its team. It also prioritizes keeping its stakeholders informed about its latest developments, as evidenced by its regularly updated newsroom. In summary, Orca Bio is a promising startup in the cell therapy market. Its focus on improving cell therapies could have a significant impact on healthcare, making it a company to watch in the biotechnology sector. Keywords: Biotechnology, Cell Therapy, Healthcare Providers, Patients, Research and Development, Commercialization, Team Culture, Stakeholder Communication, Disease Treatment, Market Potential.

Valuation $1–2.5B

Headcount 100–500

Total funding $100–500M

Unlock exact values

Power Law Unicorn$1–10B valuation tier

Investors

9 investors on Orca Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage

DCVC

Lightspeed Venture Partners

Series A 1 investor entered at this stage

Felicis

Series B+ 6 investors entered at this stage

+ND Capital

Kaiser Permanente

IMRF

8VC

Mubadala Capital

Silicon Valley Bank

Global footprint

Where Orca Bio has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States98.8%

🇨🇭 Switzerland0.4%

🇧🇷 Brazil0.4%

3 countries shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States70.9%

🇬🇧 United Kingdom10.9%

🇮🇳 India10%

🇮🇹 Italy9.1%

Top 4 markets shown

Talent graph

The shape of Orca Bio's talent

Dealroom maps Orca Bio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

12 team members profilednamed & role-tagged by Dealroom

358 employeestotal headcount

5 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Orca Bio's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$11M patent portfolio · 8 active families

Estimated portfolio value

$11M

0.76% of valuation · 69.5× smaller than top peer BioNTech ($788M)

8 active patent families

Where Orca Bio innovates Allogeneic cellAllogeneic hematopoietic stem cell transplantBiomedical engineeringHematopoietic stem cellImmunology

Where Orca Bio concentrates vs peers

Each axis is a top-10 topic across Orca Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Orca Bio

An AI-synthesized read of the highest-engagement posts about Orca Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Orca Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles